Linyan Chen

Linyan Chen

Auto-generated profile, based on publicly available information

Linyan Chen

Sichuan University 1 Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital Chengdu, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZXZhongzheng Xiang
Zhongzheng Xiang
XWXiaoyuan Wei
Xiaoyuan Wei
ZZZhuoyuan Zhang
Zhuoyuan Zhang
YTYueyang Tang
Yueyang Tang
LCLinyan Chen
Linyan Chen
LLLei Liu
Lei Liu
The clinical activity of neoadjuvant immunochemotherapy (NAIC) for treating locally advanced oral squamous cell carcinoma (LA-OSCC) remains uncertain. This single-arm, phase II trial (ChiCTR2200066119) tested 2 cycles of NAIC with camrelizumab plus nab-paclitaxel and cisplatin in LA-OSCC patients. For primary endpoint, the major pathological response (MPR) rate was 69.0% (95% confidence interval (CI): 49.2%-84.7%). The treatment was well-tolerated, with only 2 patients (6.45%) having grade 3 or 4 treatment-related adverse events during neoadjuvant treatment. For secondary endpoints, the pathological complete response rate was 41.4% (95%CI: 23.5%-61.1%) and the objective response rate was 82.8% (24/29, 95%CI: 64.2%-94.2%). The 18-month overall survival and disease-free survival probabilities were 96.77% (95%CI: 79.23%-99.54%) and 85.71% (95%CI: 53.95%-96.22%), respectively. Exploratory analysis showed that patients with MPR exhibited higher density of baseline CD4_Tfh_CXCL13 cells, and increased density of tertiary lymphoid structures after NAIC. Baseline CD4_Tfh_CXCL13 cells might be potential predictive biomarker of efficacy. The interaction between CXCL13 on CD4_Tfh_CXCL13 cells and CXCR5 on B cells may play a role in treatment response. These findings suggest the potential of NAIC as a promising treatment for LA-OSCC and offer preliminary insights into responsive biomarkers.

4 January 2021 in Oncology Nursing Forum
Verified
Journal Article
Closed access
PDF file
LCLinyan Chen
Linyan Chen
XMXiangtian Ma
Xiangtian Ma
NZNing Zhu
Ning Zhu
HXHeyu Xue
Heyu Xue
HZHao Zeng
Hao Zeng
Xuelei MaXuelei Ma
Xuelei Ma
To estimate the effectiveness of combining facial expression recognition and machine learning for better detection of distress. 232 patients with cancer in Sichuan University West China Hospital in Chengdu, China. The Distress Thermometer (DT) and Hospital Anxiety and Depression Scale (HADS) were used as instruments. The HADS included scores for anxiety (HADS-A), depression (HADS-D), and total score (HADS-T). Distressed patients were defined by the DT cutoff score of 4, the HADS-A cutoff score of 8 or 9, the HADS-D cutoff score of 8 or 9, or the HADS-T cutoff score of 14 or 15. The authors applied histogram of oriented gradients to extract facial expression features from face images, and used a support vector machine as the classifier. The facial expression features showed feasible differentiation ability on cases classified by DT and HADS. Facial expression recognition could serve as a supplementary screening tool for improving the accuracy of distress assessment and guide strategies for treatment and nursing.

23 November 2017 in Contrast Media & Molecular Imaging
Verified
Journal Article
Open access
PDF file
Wenwu LingWenwu Ling
Wenwu Ling
Xuelei MaXuelei Ma
Xuelei Ma
YLYan Luo
Yan Luo
LCLinyan Chen
Linyan Chen
HWHuiyao Wang
Huiyao Wang
DCDiming Cai
Diming Cai
Objective. This study was to investigate the features of renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions (Xp11.2-RCC) on conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS). Methods. US and CEUS features of twenty-two cases with histopathologically proven Xp11.2-RCC were retrospectively reviewed. Results. 22 patients (11 males, 11 females) were included in this study, with a mean age of 28.3 ± 20.4 years. Eight tumors (36.3%, 8/22) were in left kidney, and 14 tumors (63.7%, 14/22) were in right kidney. All tumors (100%, 22/22) were mixed echogenicity type. 13 tumors (59.1%, 13/22) presented small dotted calcifications. The boundary of 14 tumors (63.6%, 14/22) was sharp and the other 8 tumors’ (36.4%, 8/22) boundary was blurry. By CEUS, in early phase, the solid element of all tumors showed obvious enhancement. In delayed phase, 13 tumors showed hypoenhancement, seven tumors showed isoenhancement, and 2 tumors showed hyperenhancement. There were irregular nonenhancement areas in all tumors inside. Conclusions. By US and CEUS, when children and adolescents were found to have hyperechoic mixed tumor in kidney with sharp margin and calcification, and the tumors showed obvious enhancement and hypoenhancement with irregular nonenhancement areas in the tumor in early phase and delayed phase, respectively, Xp11.2-RCC should be suspected.

20 July 2026 in Cancer Research
Verified
Journal Article
Closed access
LCLinyan Chen
Linyan Chen
TFTang Feng
Tang Feng
JZJianfeng Zhou
Jianfeng Zhou
HZHao Zeng
Hao Zeng
YLYutian Lai
Yutian Lai
QLQing Li
Qing Li
Neoadjuvant immunochemotherapy (nICT) has emerged as a promising neoadjuvant strategy for esophageal squamous cell carcinoma (ESCC). Identification of the factors affecting responsiveness to nICT could help further improve treatment efficacy. In this study, we performed single-cell analysis on 14 patients with ESCC undergoing nICT and revealed tumor microenvironment (TME) features associated with differential treatment responses. Nonnegative matrix factorization (NMF) identified five coordinated cellular programs with distinct response associations. Specifically, the NMF3 program, mainly comprising immunosuppressive cell subsets, was enriched in the minimal or no pathologic tumor regression [tumor regression staging 3 (TRS3)] group, in which regulatory T cells (Treg) and dendritic cells (DC) exhibited a close correlation. In addition, elevated expression of mitochondrial transcription factor A (TFAM) in DCs was associated with increased Treg infiltration in the TRS3 group. A myeloid-specific Tfam knockout mouse model showed that TFAM deficiency reversed the immunosuppressive TME, inhibited tumor growth, and enhanced the response to anti–programmed cell death protein 1 therapy in ESCC. Mechanistically, TFAM deficiency in DCs activated the stimulator of IFN genes (STING)–TBK1–IRF3 pathway, thereby promoting DC maturation to enhance antitumor immunity. Overall, this study characterized the TME in residual ESCC after nICT and revealed an association between elevated TFAM expression in DCs and poor responsiveness to nICT. These findings indicate the critical role of TFAM deficiency in DCs in activating antitumor immunity, highlighting the potential of targeting TFAM to improve the efficacy of immunotherapy and optimize therapeutic strategies. Significance: TFAM mediates dendritic cell activation through the STING-TBK1-IRF3 pathway and is associated with responsiveness to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma, identifying TFAM as a putative immunotherapeutic target and biomarker.


15 October 2026
Verified
Other
Open access
LCLinyan Chen
Linyan Chen
TFTang Feng
Tang Feng
JZJianfeng Zhou
Jianfeng Zhou
HZHao Zeng
Hao Zeng
YLYutian Lai
Yutian Lai
QLQing Li
Qing Li
Clinicopathological information of ESCC patients with pre-treatment data of neoadjuvant immunochemotherapy.